Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling
NCT ID: NCT03457584
Last Updated: 2020-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2017-11-01
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tilt of the Intraocular Lens in Patients Undergoing Combined Phacoemulsification and Vitrectomy With Airtamponade
NCT03372759
Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
NCT04472039
New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes
NCT06948851
Instrument Tissue Interaction at the Grasp Site During Membrane Peeling of Epiretinal Membranes
NCT06459284
Effects of Pneumatic Vitreolysis on Macular Hole
NCT03677869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BSS arm
BSS is given at the end of surgery
BSS arm
epiretinal membranes are excised during membrane Peeling and BSS is left in the eye
air arm
air-tamponade is given at the end of surgery
air arm
epiretinal membranes are excised during membrane peeling and air-tamponade is left in the eye
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
air arm
epiretinal membranes are excised during membrane peeling and air-tamponade is left in the eye
BSS arm
epiretinal membranes are excised during membrane Peeling and BSS is left in the eye
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* hereditary ocular disease
* pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vienna Institute for Research in Ocular Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Prof. Dr. Oliver Findl, MBA
Prim. Prof. Dr. Oliver Findl, MBA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Findl, Prof
Role: PRINCIPAL_INVESTIGATOR
VIROS at Hanuschkrankenhaus Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VIROS - Vienna Institute for Research in Ocular Surgers - Departement of Opthalmology - Hanusch Hospital
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cysMP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.